Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-α

• Published in: International immunopharmacology 2004-02, Vol.4 (2), p.279-287
• Main Authors: Kim, Sung Hoon, Kim, Seung-Ae, Park, Mi-Kyung, Kim, Seung-Hyung, Park, Young-Doo, Na, Ho-Jeong, Kim, Hyung-Min, Shin, Min-Kyu, Ahn, Kyoo-Seok
• Format: Article
• Language: English
• Subjects: Acetophenones - pharmacology; Anaphylactic reaction; Anaphylaxis - chemically induced; Anaphylaxis - prevention & control; Animals; Anti-Allergic Agents - pharmacology; B-Lymphocytes - drug effects; B-Lymphocytes - immunology; Biological and medical sciences; Drugs, Chinese Herbal; General pharmacology; Histamine; Histamine Release - drug effects; IgE; Immunoglobulin E - biosynthesis; Immunoglobulin E - immunology; Interleukin-4 - analysis; Interleukin-4 - biosynthesis; Male; Mast Cells - drug effects; Mast Cells - immunology; Medical sciences; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; p-Methoxy-N-methylphenethylamine; Paeonia; Paeonol; Peritoneal Cavity - cytology; Pharmacognosy. Homeopathy. Health food; Pharmacology. Drug treatments; Plant Roots; Rats; Rats, Sprague-Dawley; Spleen - cytology; TNF-α; Tumor Necrosis Factor-alpha - antagonists & inhibitors; Tumor Necrosis Factor-alpha - biosynthesis
• ISSN: 1567-5769; 1878-1705
• DOI: 10.1016/j.intimp.2003.12.013

Paeonol, a major phenolic component of Moutan Cortex, was known to have antiaggregatory, antioxidant and antiinflammatory activities. In the present study, we tried to elucidate the effects of paeonol on anaphylactic reaction and its mode of action. Paeonol significantly inhibited histamine release from the rat peritoneal mast cells (RPMCs) treated with compound 48/80, a mast cell degranulator. The release of tumor necrosis factor (TNF)-α mast cell activating cytokine was significantly suppressed in RBL-2H3 mast cells pretreated with anti-dinitrophenyl (DNP) immunoglobulin E (IgE) in a dose–dependent manner. Paeonol significantly inhibited IgE production in B cells activated by anti-CD40 mAb, recombinant interleukin-4 (rIL-4) and recombinant histamine releasing factor (rHRF). Paeonol effectively downregulated the expression of IL-4 in the activated B cells by reverse transcription–polymerase chain reaction (RT–PCR). We also confirmed that paeonol effectively inhibited anaphylactic shock in mice by 90% at a dose of 0.5 mg/mouse versus PBS treated control 2 h after the i.p. injection of compound 48/80. These results suggest that paeonol has antianaphylatic activity by regulating histamine and TNF-α.